Researchers from WEHI, the Royal Melbourne Hospital & @petermaccc.bsky.social have achieved a brain cancer clinical trial world-first, providing hope to patients with low-grade gliomas. 🔗 www.wehi.edu.au/news/world-f...

So incredibly proud of my team and our collaborators. What a fantastic step forward for brain cancer clinical trials and mIDH inhibitors @braincancerlab @jimwhittle.bsky.social @saskiafreytag.bsky.social @wehi-research.bsky.social www.nature.com/articles/s41...

Excited to share the latest review paper out of our Brain Cancer lab! We focus a lot of our work on spatial heterogeneity and tumor microenvironment - but...how do you study it in practice? Read our review here discussing techniques and implications for GBM www.sciencedirect.com/science/arti...

Now on BioRxiv: we explored patient-derived GBM organoids & spheroids generated from the same resected tissue. Critically, both models maintain tumor cell composition & heterogeneity, with comparable tissue resemblance across data modalities (1/4) www.biorxiv.org/content/10.1...